SNYNF
$96.68
0.00%
Stock
Sanofi
Official Company Name: Sanofi
Stock Symbol: SNYNF
Stock Market: OTC Markets - Pink - OTC
Currency: United States dollar - USD
SNYNF Stock Price - 1 Year Price Evolution & Moving Averages
1 Year Return
▼-0.94%
Daily closing prices, with moving averages and volumes - United States dollar (USD)
Moving averages:
- — EMA20
- — SMA50
- — SMA200
France
Company Description
Sanofi, along with its subsidiaries, is involved in the research, development, manufacture, and marketing of various therapeutic solutions. It operates in three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. It offers a wide range of products for specialty care, diabetes, cardiovascular issues, and provides vaccines for various diseases, consumer healthcare products, wellness, probiotics, digestive, and nutritional products.
SNYNF Stock Data
| Open | $96.68 |
| High | $96.68 |
| Low | $96.68 |
| Close | $96.68 |
| Volume | 0 |
| Previous Close | $96.68 |
| 1-Day Change | 0.00 |
| 1-Year Change | -0.92 |
| Average Daily Volume | 15,956 |
| 52-Week High | $121.48 |
| 52-Week Low | $91.81 |
Ratios as of Jul. 4, 2025
| Beta | 0.41 |
| Trailing PE | 16.76 |
| Forward PE | 9.70 |
Disclaimer
All information and data available on Disfold is NOT FINANCIAL ADVICE. Invest at your own risk!
Past performance is not a guarantee of future performance. Patterns tend to repeat themselves, but they don't necessarily have to.
Successful backtests on past data do not guarantee the future success of the strategy backtested, especially as backtest overfitting may occur: when the price of a stock may fit particularly well a given trading strategy over a given period, but not necessarily outside of that period. Besides, backtests do not account for exact market conditions and may yield significantly different results in real trading practice (fees, slippage...).
Furthermore, even though Disfold strives to provide the best and most accurate data, errors can occur in Disfold's systems, or in our data providers' systems.
Please conduct your own due diligence to verify insights.